Mirae Asset Global ETFs Holdings’s Day One Biopharmaceuticals DAWN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$878K	Sell	40,964 -4,649	-10%	-$65.5K	﹤0.01%	1576
2025 Q4	$424K	Buy	45,613 +5,335	+13%	+$44.6K	﹤0.01%	1964
2025 Q3	$284K	Sell	40,278 -3,966	-9%	-$27.3K	﹤0.01%	2139
2025 Q2	$287K	Buy	44,244 +6,252	+16%	+$43K	﹤0.01%	2089
2025 Q1	$302K	Buy	37,992 +2,149	+6%	+$23.1K	﹤0.01%	2108
2024 Q4	$454K	Buy	35,843 +1,894	+6%	+$26.4K	﹤0.01%	1971
2024 Q3	$474K	Sell	33,949 -4,225	-11%	-$60.3K	﹤0.01%	1940
2024 Q2	$526K	Buy	+38,174	New	+$559K	﹤0.01%	1802

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's DAWN Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Day One Biopharmaceuticals (DAWN) stake by 10% in Q1 2026, selling an estimated $65.5K and leaving 40,964 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Mirae Asset Global ETFs Holdings first reported a position in DAWN in Q2 2024 and has held it in 8 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

Mirae Asset Global ETFs Holdings held 40,964 shares of Day One Biopharmaceuticals worth $878K as of Q1 2026.
Mirae Asset Global ETFs Holdings sold 4,649 Day One Biopharmaceuticals shares in Q1 2026, an estimated $65.5K.
Day One Biopharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1576 holding.
Mirae Asset Global ETFs Holdings first reported a position in Day One Biopharmaceuticals in Q2 2024 and has held it in 8 quarters since.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.